Laser eye treatment trial aims to reduce glaucoma medication use
NCT ID NCT07401290
Summary
This study is testing a laser procedure called Direct Selective Laser Trabeculoplasty (DSLT) for people with pseudoexfoliation glaucoma. The goal is to see if the laser can safely lower eye pressure and potentially reduce the need for daily eye drop medications. Researchers will follow 40 participants for one year to measure how well the treatment works and how long the effects last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOEXFOLIATION GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vance Thompson Vision
Alexandria, Minnesota, 56308, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vance Thompson Vision
Omaha, Nebraska, 68137, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vance Thompson Vision
Fargo, North Dakota, 58078, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.